Tim Corn

Tim Corn has over 15 years of experience in the biotech industry, with a focus on medical and clinical roles. Tim currently holds the position of Chief Medical Officer at Oxford Cannabinoid Technologies Holdings Plc, and also serves as a Non-Executive Director at Physiomics plc and Nerve Tumours UK. Tim'sprevious roles include Chief Medical Officer at Nodenza and Akaza Bioscience, as well as Medical Advisor at Confo Therapeutics. Tim also owns Aesclepius Consulting Ltd and has served as a Board Trustee and Chairman at Nerve Tumours UK. Tim has held multiple positions at ReNeuron Group Plc, including Non-Executive Chairman and Non-Executive Director. Tim held the position of Chief Medical Officer at Izana Bioscience and Non-Executive Director at HRA Pharma.

Tim Corn obtained their BSc in Chemistry from Imperial College London in 1971 and their MSc in Biochemistry from the same institution in 1972. Tim went on to pursue a degree in Medicine, earning an MB BS from King's College London between 1973 and 1978. Later on, they earned a degree in Neuropsychiatry from the Royal College of Psychiatrists, and a degree in Pharmaceutical Medicine from the Faculty of Pharmaceutical Medicine, both without specified start years, with the former ending in 1998 and the latter ending in 1996.